These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10333 related articles for article (PubMed ID: 12556369)

  • 1. Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma.
    Hearle N; Damato BE; Humphreys J; Wixey J; Green H; Stone J; Easton DF; Houlston RS
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):458-62. PubMed ID: 12556369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma.
    Buecher B; Gauthier-Villars M; Desjardins L; Lumbroso-Le Rouic L; Levy C; De Pauw A; Bombled J; Tirapo C; Houdayer C; Bressac-de Paillerets B; Stoppa-Lyonnet D
    Fam Cancer; 2010 Dec; 9(4):663-7. PubMed ID: 20842456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
    Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D
    Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma.
    Soufir N; Lacapere JJ; Bertrand G; Matichard E; Meziani R; Mirebeau D; Descamps V; Gérard B; Archimbaud A; Ollivaud L; Bouscarat F; Baccard M; Lanternier G; Saïag P; Lebbé C; Basset-Seguin N; Crickx B; Cave H; Grandchamp B
    Br J Cancer; 2004 Jan; 90(2):503-9. PubMed ID: 14735200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
    Tachibana I; Smith JS; Sato K; Hosek SM; Kimmel DW; Jenkins RB
    Am J Med Genet; 2000 May; 92(2):136-41. PubMed ID: 10797439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF.
    Rizos H; Darmanian AP; Holland EA; Mann GJ; Kefford RF
    J Biol Chem; 2001 Nov; 276(44):41424-34. PubMed ID: 11518711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 is a major inactivation target in hepatocellular carcinoma.
    Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H
    Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
    Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
    Abdel-Rahman MH; Pilarski R; Massengill JB; Christopher BN; Noss R; Davidorf FH
    Melanoma Res; 2011 Jun; 21(3):175-9. PubMed ID: 21412176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
    van der Velden PA; Metzelaar-Blok JA; Bergman W; Monique H; Hurks H; Frants RR; Gruis NA; Jager MJ
    Cancer Res; 2001 Jul; 61(13):5303-6. PubMed ID: 11431374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression.
    Ming Z; Lim SY; Rizos H
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33076392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
    Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
    Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas.
    Shintani S; Nakahara Y; Mihara M; Ueyama Y; Matsumura T
    Oral Oncol; 2001 Sep; 37(6):498-504. PubMed ID: 11435176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
    Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P; Zaravinos A; Zioga M; Spandidos DA
    Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
    Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 517.